Date: December 10,    2014     Author: gphadmin     Comments: No Comments     Categories: Gregory Pharmaceuticals News

Allows BioPharmX to Leverage UPM’s Outsourced Manufacturing for Anticipated High-Volume Consumer Product BRISTOL, Tenn., (December 10, 2014 /PRNewswire/) − UPM Pharmaceuticals, a division of Gregory Pharmaceutical Holdings, Inc., has reached an agreement with BioPharmX, Inc. (OTCQB: BPMX) to commercially manufacture solid dose iodine supplement tablets for the consumer products sector. The.

Date: December 08,    2014     Author: gphadmin     Comments: No Comments     Categories: Gregory Pharmaceuticals News

Welcome to Gregory Pharmaceutical Holdings. Check back for more news.